Barrera-Chimal, Jonatan http://orcid.org/0000-0002-0711-5092
Lima-Posada, Ixchel
Bakris, George L.
Jaisser, Frederic http://orcid.org/0000-0001-9051-1901
Article History
Accepted: 13 September 2021
First Online: 21 October 2021
Competing interests
: G.L.B. is the principal investigator of FIDELIO (Bayer), serves on the steering committee of the FLOW trial (Novo Nordisk) and the CALM-2 trial (Vascular Dynamics), and is a consultant for Merck, Relypsa, Alnylam and KBP Biosciences. F.J. received research grants from AstraZeneca and Bayer SAS and honoraria from AstraZeneca, Bayer SAS and KBP Biosciences. The other authors declare no competing interests.